Wednesday, October 21, 2020
Home > Investing > Advisor > GrowLife, Inc. Receives Patent Issuance on Commercial Cloning System Designed for Hemp and Cannabis Industries
AdvisorBusinessCompaniesEditorialInvestingMarketsStocks

GrowLife, Inc. Receives Patent Issuance on Commercial Cloning System Designed for Hemp and Cannabis Industries

GrowLife, Inc. Receives Patent Issuance on Commercial Cloning System Designed for Hemp and Cannabis Industries

KIRKLAND, Wash. – July 11, 2019 — GrowLife, Inc. (OTC: PHOT) (“GrowLife” or the “Company”), one of the nation’s most recognized indoor cultivation product and service providers, today announced that the Canadian patent regulatory authority issued the Company a patent on the design of its EZ-CLONE Pro Commercial Cloning System entitled “Aeroponics System with Rack and Tray” under patent number 2,985,009.

The innovative product was developed by GrowLife’s recently majority acquired EZ-CLONE Enterprises, Inc. which specializes in the manufacturing of cloning and propagation equipment. The newly patented design was developed for commercial plant cultivators in the hemp and marijuana industries to provide a sustainable, user-friendly way to fill the growing demand for clones. The award-winning EZ-CLONE Pro is one-of-a-kind in both design and capacity with the ability to produce an industry-leading 459 cutting sites.

“The issuance of this patent illustrates how innovative this product is and how much it can disrupt the entire cannabis and hemp industries,” said GrowLife CEO Marco Hegyi. “Commercial cultivators are searching for solutions that enable them to grow more consistent and healthy plants as fast as possible, and we are able to deliver this to them. Through decades of proven experience and under the leadership of Billy Blackburn, EZ-CLONE has built a legacy of the finest cloning products available and protecting this design was extremely important for the future of our company, as we further position ourselves as the leaders in hemp and cannabis cloning.”

The demand for hemp and cannabis clones is increasing through continued cannabis legalization throughout the country as well as the passage of the United States 2018 Farm Bill. According to the Global State of Hemp, the global hemp market is expected to reach $5.7 billion across all markets in 2022. This is representing a three-year compound annual growth rate of nearly 18 percent.

“Our commercial cloning unit is one of the largest and most effective products on the market. Our customers are seeing almost 100 percent viability in clone production and generating roots up to 50 percent faster than conventional propagation methods. We can now proudly say that our unit is not only effective but proprietary and patented” added GrowLife Executive Vice-President of Research at Development William “Billy” Blackburn.


Disclaimer
All stock recommendations and comments are the opinion of writer.

Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion.

All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.

You should be aware of the risks involved in stock investing, and you use the material contained herein at your own risk. Neither Market-Advisor.com nor any of its suppliers guarantee its accuracy or validity, nor are they responsible for any errors or omissions which may have occurred. The analysis, ratings, and/or recommendations made by Market-Advisor.com, and/or any of its suppliers do not provide, imply, or otherwise constitute a guarantee of performance.

Market-Advisor.com is comprised of reports, if any, embodying a unique system of stock analysis. Accuracy and completeness cannot be guaranteed. Users should be aware of the risks involved in stock investments. It should not be assumed that future results will be profitable or will equal past performance, real, indicated or implied.

The material on this website are provided for information purpose only. Market-Advisor.com does not accept liability for your use of the website. The website is provided on an “as is” and “as available” basis, without any representations, warranties or conditions of any kind.